Diamyd Medical AB (publ) (DMYD-B.ST) - Stock Prices, Stock Peers & Analysis

Home
DMYD-B.ST

Company Name	Diamyd Medical AB (publ)
Symbol	DMYD-B.ST
Currency	SEK
Price	13.3
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	1,226,345,120
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	6.41 - 20.992
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Ulf Hannelius MBA, Ph.D.
Website	https://www.diamyd.com

An error occurred while fetching data.

About Diamyd Medical AB (publ)

Diamyd Medical AB (publ) develops therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy diabetes vaccine, which is in phase IIb clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes; and Remygen, an oral regenerative and immunomodulatory drug candidate, which is